When Patients Look Abroad: What Bangladesh Must Learn
Md. Kafi Khan
Published: 17 Nov 2026, 12:27 PM
A recent image asks whether a Bangladeshi vascular surgeon could open an office in Kolkata or Tripura, given the presence of foreign hospital representatives in Bangladesh. It is a fair question about professional opportunity and reciprocity. But it also points to a larger concern that deserves our attention: why do so many Bangladeshis seek medical treatment abroad, and what would make them more confident in the care available at home?
The image cannot tell us who operates the offices shown, what services they provide or whether they have the required permissions. It also does not prove that a Bangladeshi doctor would be refused permission to establish a professional presence in India. We should be careful not to draw conclusions from an image alone.
There is also an important difference between a hospital’s patient-coordination office and a doctor’s right to practise medicine. Bangladesh has a process through the Bangladesh Investment Development Authority for foreign companies seeking permission to establish branch, liaison or representative offices. In India, a foreign-trained doctor must meet the applicable medical-registration requirements to practise clinically. Permission to run an office does not, by itself, allow a doctor to examine patients or perform surgery. The rules governing each activity should be made clear, including the routes available to Bangladeshi professionals seeking lawful opportunities abroad.
The question should not be framed as an accusation against any country or profession. It should prompt a practical discussion: Are foreign hospital representatives properly authorised? Are patients given clear information about the services being promoted? What legal permissions would a Bangladeshi specialist need to work across the border? These questions deserve answers based on rules and evidence.
Why patients travel
People go abroad for treatment for different reasons. Some need a particular service or specialist that is difficult to access in Bangladesh. Some seek another medical opinion or want several tests and consultations coordinated by one institution. Others place their confidence in a hospital because of a previous experience, a recommendation from someone they trust, or clearer communication about the treatment and its likely cost. Proximity, transport, language and patient-support networks can also shape the decision.
This trend should not be taken as a judgment on all Bangladeshi doctors. Many are highly capable and serve patients with dedication. Yet patients experience a whole system, not only an individual doctor. They need timely appointments, reliable diagnostic services, clear explanations, trained nurses and technical staff, functioning equipment, transparent bills and proper follow-up. When these parts do not work together, even good clinical expertise may not be enough to give a patient confidence.
The figures indicate the scale of cross-border treatment, but they need to be read carefully. India’s Ministry of Tourism recorded 1,750,165 arrivals from Bangladesh in 2024. It classified 27.56% of these arrivals as medical visits. That implies about 482,000 medical-purpose arrivals. It is an estimate based on the published share, not proof that every traveller was forced to leave Bangladesh or that every treatment sought abroad was unavailable here.
The financial burden is also significant. The World Health Organization’s Bangladesh UHC profile reports that household out-of-pocket payments accounted for 68.5% of total health expenditure in the data it presents. The profile also cites an average out-of-pocket cost of Tk 220,593 for a patient seeking healthcare abroad, based on a surveillance study covering December 2022 to November 2023. These figures show how costly illness can be for families. They do not explain every individual decision or establish that treatment abroad is always more effective or more expensive than treatment at home.
In 2025, WHO cited a UHC service-coverage index of 54 out of 100 for Bangladesh and reported that 41.7% of the population had experienced financial hardship because of out-of-pocket health expenditure. These are different measures from the expenditure share above, but both point to a need to improve access and protect families from the cost of care.
The system behind the doctor
The question is not simply whether Bangladesh has specialists. It is whether patients can reach the right specialist in time, receive an accurate diagnosis, understand their options and obtain safe care without avoidable uncertainty.
A patient’s treatment may involve a general practitioner, a specialist, laboratory tests, imaging, surgery, medicines and follow-up. If these services are poorly connected, patients and families have to manage the process themselves. They may repeat tests, receive conflicting advice or struggle to understand who is responsible for the next step. This can weaken confidence, even when capable doctors are available.
The workforce must also be considered as a whole. Doctors are essential, but so are nurses, midwives, laboratory and imaging professionals, pharmacists, rehabilitation workers and hospital managers. WHO’s human-resources profile for Bangladesh highlights the need for better workforce planning and capacity. Investment in medical education should therefore be matched by attention to staffing, distribution, professional development and the working conditions that help skilled people remain in the health system.
Hospitals also need to maintain the equipment they buy and ensure that staff are trained to use it safely. Advanced technology alone cannot guarantee better care. It must be supported by reliable maintenance, supplies, clinical protocols and enough appropriate cases to keep teams competent.
Patient safety should be treated as a measure of quality, not as a public-relations exercise. All health systems face risks. What matters is whether hospitals identify problems, report incidents, learn from them and improve their practice. WHO’s Global Patient Safety Action Plan 2021–2030 offers a framework for reducing avoidable harm and making care safer and more respectful.
Trust also depends on how patients are treated and informed. People should be told, in language they understand, what is known about their condition, why a treatment is being proposed, what alternatives exist, what the material risks are and what the treatment may cost. They should be able to ask questions, seek another opinion and obtain their medical records. Hospitals should have clear channels for complaints and for follow-up after treatment.
What should change
Bangladesh needs better evidence about why people travel for medical treatment. The government should regularly examine which conditions lead patients abroad, what services they seek, how they are referred, what they spend and what care they need after returning. The information should distinguish between treatment that is not reasonably available at home and travel driven by preference, convenience or confidence. Patient privacy must be protected. Without reliable evidence, policy may end up responding to isolated stories or uncertain estimates.
The next step is to plan for specific services. Government, professional bodies and hospitals should identify where local capacity is inadequate, where existing services are hard to reach and where quality needs improvement. Cancer, heart and vascular care, kidney disease and transplantation, for example, each require different combinations of specialists, technology, nursing, diagnostics and follow-up. Plans should say what can realistically be improved, over what period and with what resources.
Hospital oversight should also become more useful to patients. Licensing and inspection should consider safety, staffing, infection prevention, equipment maintenance, clinical governance and complaint handling. The public should be able to find out which services a facility is authorised and equipped to provide. If hospitals publish outcomes, the figures should be presented responsibly and account for differences in the patients they treat.
Financial protection needs sustained attention. The government should review progress under the Health Care Financing Strategy and set clear targets for reducing the burden of direct payments, particularly for lower-income families and people with serious illness. Options may include stronger public primary and referral care, targeted subsidies and carefully designed pooled financing or insurance arrangements. Such schemes need clear benefit packages, reliable providers and safeguards against unnecessary treatment. Insurance by itself cannot solve a shortage of services or a lack of quality.
Hospitals and professional institutions can improve continuity of care by giving patients usable copies of their records, test results and treatment plans. Secure digital systems could help doctors coordinate care and reduce unnecessary repeat tests, provided that privacy and consent are protected. Patients should also have access to a credible second-opinion process before making major medical or financial decisions.
The rules governing foreign hospital representatives and referral agencies should be transparent. Patients should know the legal status of an agency, what it does and whether it receives a referral fee or commission. Promotional claims about treatment outcomes, costs or the absence of local options should be supported by evidence. The same clarity should apply to Bangladeshi doctors seeking professional opportunities abroad.
Bangladesh and India should make the rules for representative offices, teleconsultation, visiting specialists and clinical practice easy to understand. Any arrangement should respect the laws and professional standards of both countries, protect patients and clarify who is responsible for the care provided. Reciprocity is best pursued through fair, transparent procedures, not assumptions that every activity is treated identically on both sides.
Earning confidence
Patients should remain free to seek treatment abroad when that is their informed choice or when their medical needs require it. The goal should not be to restrict travel or suggest that overseas care is automatically better. The goal should be to make safe, competent and respectful care more accessible in Bangladesh, and to give patients honest advice about what can and cannot be provided locally.
The image raises a question about professional access, but the larger issue is public confidence. As a citizen, I believe progress should be measured by whether a patient can obtain appropriate care at home when it is clinically available, receive an honest referral when it is not, understand the likely costs and remain protected throughout the process.
A stronger health system will require more than new buildings or advanced machines. It will require capable professionals working in a dependable system, effective oversight, fairer financing and respect for patients. Bangladesh should aspire not merely to retain patients, but to earn their confidence.
